Quick Summary

Isatis tinctoria, also known as woad, is a traditional medicinal herb from the Brassicaceae family with a long history of use in Chinese medicine. It contains bioactive compounds that may have anti-inflammatory, antiviral, and immune-modulating properties. Isatis is commonly used in multi-herbal formulations aimed at supporting the treatment of viral infections, inflammatory skin conditions, and as a potential adjunct therapy in respiratory illnesses, including COVID-19. Experimental and clinical studies suggest its phytochemicals may target key inflammatory pathways and viral replication mechanisms, though more high-quality clinical trials are needed to confirm these effects.

What is it?

Isatis tinctoria (woad) is a herbaceous plant belonging to the mustard family (Brassicaceae). It has been utilized for centuries in traditional Chinese medicine (TCM) for its purported medicinal properties. The plant contains various active compounds that have been studied for their biological activities relevant to inflammation, immunity, and infections.

Traditional Uses

Traditionally, Isatis tinctoria has been used in Chinese herbal medicine as part of multi-herbal formulas to clear heat, resolve toxicity, and eliminate dampness. It has been applied in the management of viral infections, inflammatory skin diseases such as psoriasis, and respiratory illnesses. Some formulations also use Isatis topically for skin conditions associated with viral infections.

Active Compounds

Key bioactive compounds in Isatis tinctoria include indirubin, various alkaloids, flavonoids, and other phytochemicals. Indirubin in particular has been identified as a major metabolite that may influence inflammatory signaling pathways. Other constituents have been implicated in modulating immune and antiviral responses via pathways such as PI3K/Akt and NF-κB/MAPK.

Potential Benefits with Evidence Levels

  • Anti-inflammatory effects – Supported by preclinical and early clinical evidence. Studies show petroleum ether extracts of Isatis reduced inflammation in mouse models of allergic contact dermatitis and inhibited pro-inflammatory cytokines and mast cell degranulation in vitro (Lotts et al. 2020). Indirubin improved survival and lowered inflammation in mouse sepsis models by targeting key inflammatory pathways (Li et al. 2025).
  • Antiviral potential, including activity against HPV and respiratory viruses – Supported by limited controlled clinical evidence and preclinical research. Chinese medicine formulas containing Isatis were associated with increased clearance rates of high-risk HPV and reduced HPV viral load (Huang et al. 2023). Topical multi-herbal preparation Paiteling with Isatis showed histologic remission in HPV-induced cervical lesions in case reports (Li et al. 2025). TCM preparations with Isatis used adjunctively for respiratory infections including COVID-19 showed some symptom improvement, though evidence certainty is low (multiple systematic reviews 2021-2023).
  • Potential supportive role in dermatological conditions including psoriasis and chemotherapy-induced oral mucositis – Suggested by meta-analyses of randomized trials with moderate to low quality evidence. Isatis-containing herbal medicines improved psoriasis severity, quality of life, and reduced inflammatory markers (Luo et al. 2020; Jo et al. 2023). Heat-clearing TCM gargles containing Isatis reduced incidence and severity of chemotherapy-induced oral mucositis (Lin et al. 2021).
  • Modulation of immune and inflammatory signaling pathways – Indicated by preclinical and network pharmacology studies. Isatis compounds were involved in regulating PI3K/Akt and NF-κB/MAPK pathways in models of herpes simplex keratitis and sepsis (Xiao et al. 2025; Li et al. 2025).

Side Effects

Current clinical evidence does not suggest significant safety concerns related to Isatis tinctoria when used as part of herbal formulations. Adverse event rates in trials were generally similar to control groups. Mild transient local irritation was reported in a few topical use cases. No serious adverse effects were specifically attributed to Isatis. Minor transient vaginal burning was noted in two cases using topical Paiteling containing Isatis. Some formulations including Isatis may cause mild gastrointestinal discomfort. Data regarding side effects from isolated Isatis use are limited.

Drug Interactions

No specific drug interactions involving Isatis tinctoria have been documented in the reviewed literature. However, as with many herbal medicines, potential interactions with conventional antiviral or anti-inflammatory drugs cannot be excluded. Caution is advised when combining Isatis with such medications.

Who Should Avoid It

Individuals with known hypersensitivity or allergy to mustard family plants (Brassicaceae) should exercise caution when considering Isatis. There are no explicit contraindications identified in current clinical data. Due to insufficient safety information, pregnant and breastfeeding women should avoid use or only consider it if benefits are judged to outweigh risks under professional supervision.

Evidence Limitations

Most clinical studies involve complex multi-herbal formulations containing Isatis tinctoria rather than the isolated herb, which limits the ability to attribute effects directly to Isatis. Many trials exhibit methodological limitations such as small sample sizes, risk of bias, and lack of blinding. High-quality randomized controlled trials focused on isolated Isatis are lacking. The specific active components, appropriate dosages, and detailed mechanisms of action require further investigation. Long-term safety data are also insufficient.

References

Last Reviewed

April 2024

Informational Disclaimer: The content provided here is for educational purposes only and does not constitute medical advice. While Isatis tinctoria has been studied in various preclinical and clinical settings, more robust research is needed to confirm its efficacy and safety. Always consult a qualified healthcare professional before starting any new herbal treatment, especially if you have existing health conditions or are taking other medications.